Skip to main content

People Colin Bennett

Oxford Martin Visiting Fellow, Oxford Martin Programme on Affordable Medicines

Colin Bennett

Oxford Martin Visiting Fellow

Colin Bennett is a Visiting Fellow with the Oxford Martin Programme on Affordable Medicines from July 2017.

Colin joined Shell International in Den Haag and served in the group’s worldwide operations. He held executive positions within the French group TOTAL  in strategic planning and development economics and at ExxonMobil, where he was a member of the Management Council, Vice President and Director overseeing the business, scientific and technical service directorates at Mobil Gas Marketing and Mobil North Sea.

He has worked extensively across the public service and not-for-profit sectors, including in local government, environment, education, health, social care, justice and prison reform. He was Chief Executive at the Chief Fire Officers Association and Presidential Advisor to the ministerial sounding board, and was also Chief Executive at the National Open College Network.  

Colin was Chief Executive at the national mutual Benenden Healthcare and Hospital Group, founded in 1905 for patients suffering tuberculosis unable to meet cost of long term care, then of early influence in founding National Insurance and the NHS. As part of that role, he was  a director delegate member of the Association Internationale de la Mutualité, an international umbrella organisation of not-for-profit healthcare federations procuring or providing medical coverage to around 240 million people across Europe, Latin America, Africa and the Middle East.

He has also been external Executive Business Advisor to the Environment Agency under UK Treasury, Office of Government Commerce programme to leverage international treaty objectives for air, water and ground quality through the introduction of enabling technology. 

He was appointed Alan Tayler Advisory Fellow (Mathematics) by the University of Oxford where he is also advisor to the directors of the joint EPSRC Centre for Doctoral Training, industrially focused mathematical modelling programme at the Mathematics Institute. Colin has been a guest lecturer in Engineering at the University of Aberdeen and led an inaugural post graduate external mentorship programme at the Kuala Lumpur Business School, University of Nottingham Malaysia Campus.

He is Chair of the medical biotech company EnteroBiotix focussed on using the body’s microorganisms to prevent and treat debilitating infections and disease. Colin is also Chairman at the community interest company EuroBiotix CiC formed to promote research in to the human microbiota and expand safe access to faecal microbiota transplantation. In addition to healthcare he has led successful business start-ups in publishing, tourism and executive management.

Colin holds other board positions at the Shakespeare Birthplace Trust and also in biodiversity and international community conservation with The Wallacea Trust focussed around worldwide scientific data collection and expedition sites of Operation Wallacea. 

Oxford Martin Programme on Affordable Medicines

Oxford Martin Programme on Affordable Medicines

Oxford Martin Visiting Fellow